Gabriele Donati, Lorenzo Gasperoni, Marianna Napoli, Anna Scrivo, Fulvia Zappulo, Chiara Abenavoli, Lilio Hu, Andrea Angelini, Miriam Di Nunzio, Edoardo Tringali, Alessandra Cingolani, Beatrice Claudia Marchegiani, Angelo Rigotti, Gaetano La Manna
INTRODUCTION: High-flux hemodialysis membranes may modulate the cytokine storm of SARS-CoV-2, but their impact on chronic hemodialysis (CHD) patients is unknown. The aim of the study was the evaluation of asymmetric cellulose triacetate (ATA) and polymethylmethacrylate (PMMA) dialyzers on inflammatory markers and clinical outcomes in CHD patients with SARS-CoV-2. METHODS: A prospective, observational study on CHD patients with SARS-CoV-2 was carried out. Patients were enrolled from March 2020 to May 2021...
November 2, 2022: Blood Purification